Related Experiment Video
Updated: Apr 23, 2026

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
Published on: July 24, 2019
Developing a Virtual Research Environment in the Parkinson's Progression Markers Initiative: myPPMI
Craig E Stanley1, Kimberly Fabrizio1, Bridget A McMahon1
1Institute for Neurodegenerative Disorders, New Haven, CT.
None:
In the 15 years since Parkinson's Progression Markers Initiative (PPMI) launched, research conduct has advanced with broader connectivity, enabling virtual and hybrid methods for recruitment, engagement, education, and data collection. To meet evolving needs, PPMI created "myPPMI," which has grown from an informational portal to a multi-country, participant-centered, virtual research environment integrating education, screening, e-consent, longitudinal non-motor and motor assessments, and biospecimen referral. Built on a secure, cloud-native architecture with daily analytics and a multi-tier support model, myPPMI enables precision recruitment, real-time eligibility matching, and standardized low-burden data capture across studies. The platform is designed to enable focused data collection from individuals or groups based on the data they have already provided. This strategy provides the tools to establish precise subsets of high interest that could be targeted for further data acquisition. Usability testing and rapid global scaling demonstrate a generalizable, decentralized framework for biomarker-driven, Parkinson's disease research. ANN NEUROL 2026.
More Related Videos
08:36The Immersive Cleveland Clinic Virtual Reality Shopping Platform for the Assessment of Instrumental Activities of Daily Living
Published on: July 28, 2022
06:32Author Spotlight: Automated Deep Brain Stimulation for Parkinson's Disease - Exploring the Possibilities and Challenges of Home Monitoring
Published on: July 14, 2023
Related Concept Videos
Parkinson's Disease: Overview
Parkinson Disease l: Introduction
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson Disease ll: Pathophysiology